Log in to save to my catalogue

Scutellarin ameliorates neonatal hypoxic-ischemic encephalopathy associated with GAP43-dependent sig...

Scutellarin ameliorates neonatal hypoxic-ischemic encephalopathy associated with GAP43-dependent sig...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d4537725441a42519ba239dbc2428080

Scutellarin ameliorates neonatal hypoxic-ischemic encephalopathy associated with GAP43-dependent signaling pathway

About this item

Full title

Scutellarin ameliorates neonatal hypoxic-ischemic encephalopathy associated with GAP43-dependent signaling pathway

Publisher

London: BioMed Central Ltd

Journal title

Chinese medicine, 2021-10, Vol.16 (1), p.1-105, Article 105

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Neonatal hypoxic-ischemic encephalopathy (HIE) refers to the perinatal asphyxia caused by the cerebral hypoxic-ischemic injury. The current study was aimed at investigating the therapeutic efficacy of Scutellarin (Scu) administration on neurological impairments induced by hypoxic-ischemic injury and exploring the underlying mechanisms. M...

Alternative Titles

Full title

Scutellarin ameliorates neonatal hypoxic-ischemic encephalopathy associated with GAP43-dependent signaling pathway

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d4537725441a42519ba239dbc2428080

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d4537725441a42519ba239dbc2428080

Other Identifiers

ISSN

1749-8546

E-ISSN

1749-8546

DOI

10.1186/s13020-021-00517-z

How to access this item